News

Indonesia’s Ministry of Health now enforces annual internal audits for medical device distributors under PP No. 28/2025.

Vietnam’s DAV intensifies inspections through March 2026, targeting cosmetic notification compliance and Product Information File readiness.

China’s H1 medical device imports reached approx. USD 24 billion, showing stable demand amid shifts in key categories and sourcing countries.

China signaled a shift in medical device procurement away from price focus, emphasizing clinical use and product quality.

China’s National Health Commission approved 14 new “Three New Foods,” covering novel food raw materials, food additives, and food-related products, with defined compliance conditions for use

China’s GACC Order No. 280 formalizes registration rules for overseas food manufacturers exporting to China.

China’s SAMR approved six imported health foods in 2025, ending a seven-year pause. Learn what this means for overseas brands.

Indonesia has expanded retail access for selected low-risk medical devices, opening new sales channels to benefit consumers.

China's multi-ministry pilot to classify imported food-medicine substances by use aims to simplify customs clearance for non-medicinal imports.

Indonesia’s Ministry of Health will temporarily close key medical device licensing and registration systems from December 2025 to January 2026

Vietnam’s Ministry of Health has delegated medical device oversight to specialized agencies, impacting registration and post-market surveillance.

China will launch a cosmetic e-label pilot on February 1, 2026. Explore the labeling requirements and what preparation is required.

NMPA issues draft changes to China’s IVD Classification Catalogue, adding new risk classes and technology platforms.

Indonesia revises medical device and IVD registration timelines under Permenkes 11/2025, extending approval timelines.

Taiwan’s Ministry of Health and Welfare tightens cosmetic ingredient rules for hair dyes, children’s cosmetics, and oral care products.

NMPA outlines cosmetics regulation reforms, aiming to expand non-animal testing, streamline registration, and drive ingredient innovation.

China’s NMPA has issued a new GMP for medical devices, effective Nov 1 2026, with stricter quality, personnel, and supplier controls.

Malaysia’s MDA introduces a two-year validity for Product Classification Letters from May 1, 2025 – see timelines and requirements.

Rising Class III medical device registrations in China during Q1–Q3 2025 signal opportunities for foreign manufacturers of advanced devices.

China’s 2024 NIFDC Cosmetics Review Report showcases soaring registrations and key opportunities for global beauty brands.